Gary Yeung, CFA
Founder and Managing Partner, YK Bioventures
Gary Yeung is the Founder and Managing Partner of YK Bioventures, bringing over 25 years of life sciences investment and executive leadership experience. Throughout his career, Gary has raised over $800 million in capital and invested in more than 25 private life sciences companies.
As a senior executive, he played key leadership roles in building and scaling Guardant Health (NASDAQ: GH), Annexon Biosciences (NASDAQ: ANNX), and Erasca (NASDAQ: ERAS). Previously,
Gary spent 12 years at Genentech leading operational teams that filed 42 INDs and launched multiple FDA-approved therapies. He began his career at McKinsey & Company and GE.
Gary holds an MBA from UCLA, a B.S. in Chemical Engineering from UC Berkeley, and is a CFA charterholder.